NCT07403136 2026-04-15Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCCFudan UniversityPhase 2 Suspended104 enrolled
NCT06122493 2023-11-08Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell CarcinomaRuijin HospitalPhase 2 Recruiting48 enrolled